Influenza virus split vaccine (0.7mL/vial)

BIOLOGICAL2 trials

Sponsors

Shanghai Institute Of Biological Products

Conditions

Influenza

Phase 1

A Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above

RecruitingNCT07302256

Shanghai Institute Of Biological ProductsInfluenza

Start: 2025-12-16End: 2026-08-31Target: 120Updated: 2026-01-14

Phase 2

Phase Ⅱ Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above

Not yet recruitingNCT07327398

Shanghai Institute Of Biological ProductsInfluenza

Start: 2026-01-07End: 2026-09-30Target: 1200Updated: 2026-01-15